Neuphoria Therapeutics, Inc. (NEUP)
3.06
-0.30
(-8.93%)
USD |
NASDAQ |
Oct 29, 16:00
3.10
+0.04
(+1.31%)
After-Hours: 04:21
Neuphoria Therapeutics Net Income (Quarterly) : -4.904M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.904M |
| March 31, 2026 | -0.5051M |
| December 31, 2025 | 1.864M |
| September 30, 2025 | -9.906M |
| March 31, 2025 | 11.26M |
| Date | Value |
|---|---|
| December 31, 2024 | -1.943M |
| September 30, 2024 | -0.8048M |
| June 30, 2024 | -2.687M |
| March 31, 2024 | -2.778M |
| December 31, 2023 | -4.554M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Agenus, Inc. | -0.567M |
| Amgen, Inc. | 2.375B |
| Anika Therapeutics, Inc. | 3.309M |
| BioCryst Pharmaceuticals, Inc. | 78.40M |
| Imunon, Inc. | -2.814M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.174M |
| Total Expenses (Quarterly) | 6.079M |
| EPS Diluted (Quarterly) | -0.9063 |
| Enterprise Value | -3.273M |
| Gross Profit Margin (Quarterly) | 85.89% |
| Profit Margin (Quarterly) | -417.7% |
| Earnings Yield | -202.1% |
| Normalized Earnings Yield | -159.57 |